SPARC and breast cancer: To investigate the mechanisms leading to PD-1 neg Treg generation in ECM3 + tumors, we employed murine BC cell lines expressing different levels of the matricellular protein SPARC (secreted protein acidic and rich in cysteine, also known as osteonectin or BM-40), the leading gene defining the ECM3 phenotype [6].